United Therapeutics (UTHR) Earnings Date & Reports

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

UTHR is expected to report earnings to rise 21.82% to $7.09 per share on August 05

United Therapeutics UTHR Stock Earnings Reports

Q2'26

Est.

$7.09

Q1'26

Missed

by $1.17

Q4'25

Beat

by $0.60

Q3'25

Missed

by $0.16

Q2'25

Missed

by $0.94

The last earnings report on May 06 showed earnings per share of $5.82, missing the estimate of $6.99. With 98.25K shares outstanding, the current market capitalization sits at 22.48B.

View a ticker or compare two or three

UTHR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days